Clinical Trial

Safety and Efficacy Study of GEB-101 Injection in Subjects With TGFBI-related Corneal Dystrophy

Name: Safety and Efficacy Study of GEB-101 Injection in Subjects With TGFBI-related Corneal Dystrophy — clinical trial record (NCT07750678)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: CLARITY

Not Yet Recruiting Phase 1/2

View on ClinicalTrials.gov →

Summary

The goal of this clinical trial is to evaluate the safety and efficacy of GEB-101 injection in subjects with TGFBI-related Corneal Dystrophy

Trial Details

NCT Number	NCT07750678
Lead Sponsor	GenEditBio Limited
Conditions	Hereditary Corneal Dystrophy, Corneal Abnormality, Corneal Dystrophies, Corneal Dystrophies, Hereditary
Enrollment	30 participants
Start Date	2026-08
Primary Completion	2027-08 (estimated)
Study Completion	2028-12 (estimated)
Updated on ClinicalTrials.gov	2026-08-06